| Deal Information |
|
||||
| Credit & Investment Research |
|
||||
| Market Research |
|
||||
| News |
|
||||
Boehringer Ingelheim Pharma acquires Johnson & Johnson Inc-Zantac from Johnson & Johnson Inc
|
US - Boehringer Ingelheim Pharmaceuticals Inc, a unit of Boehringer Ingelheim GmbH's Boehringer Ingelheim International GmbH subsidiary, agreed to acquire the over-the-counter Zantac product line of Johnson & Johnson Inc, a manufacturer and wholesaler of medical equipment products, for…
|
|
Copyright © 2012 Alacra, Inc., 100 Broadway, Suite 1100, New York, NY 10005. All rights reserved.
Reproduction in whole or in part in any form or medium without express written permission is prohibited.
Reproduction in whole or in part in any form or medium without express written permission is prohibited.